Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxduo extension study in acute pain
NCT00565760Phase 3Completed
- Sponsor
- QRxPharma Limited
- Start
- Nov 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of moxifloxacin + ibuprofen in acute pain, sponsored by QRxPharma Limited. Started Nov 2007; status: completed.
02
Drugs
moxifloxacin + ibuprofen
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT00565760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00565760.